Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index.

Kawashiri, Shin-Ya; Kawakami, Atsushi; Iwamoto, Naoki; Fujikawa, Keita; Aramaki, Toshiyuki; Tamai, Mami; Yamasaki, Satoshi; Nakamura, Hideki; Ueki, Yukitaka; Migita, Kiyoshi; Mizokami, Akinari; Origuchi, Tomoki; Aoyagi, Kiyoshi; Eguchi, Katsumi

Kawashiri, Shin-Ya; Kawakami, Atsushi; Iwamoto, Naoki; Fujikawa, Keita; Aramaki, Toshiyuki; Tamai, Mami; Yamasaki, Satoshi; Nakamura, Hideki; Ueki, Yukitaka; Migita, Kiyoshi; Mizokami, Akinari; Origuchi, Tomoki; Aoyagi, Kiyoshi; Eguchi, Katsumi.

Affiliation

Kawashiri SY; Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. shin-ya@hotmail.co.jp

Mod Rheumatol ; 21(4): 365-9, 2011 Aug.

Article in En | MEDLINE | ID: mdl-21229375

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal/administration & dosage; Antirheumatic Agents/administration & dosage; Arthritis, Rheumatoid/drug therapy; Severity of Illness Index; Adult; Aged; Arthritis, Rheumatoid/blood; Blood Sedimentation; Female; Humans; Infliximab; Male; Middle Aged; Prospective Studies; Remission Induction; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Severity of Illness Index / Antirheumatic Agents / Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2011 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google